While the metabolic effects of GLP-1-RA, particularly on weight loss and glucose regulation, are well-characterized (Fig
[1] These medications work by mimicking the action of naturally occurring GLP-1, an incretin hormone that stimulates insulin secretion in response to food intake, suppresses glucagon release, slows gastric emptying, and promotes satiety through central nervous system pathways
Facility implications of an oral solid dosage format for GLP-1s: Shifting from an injectable to an oral dosage form could dramatically streamline the GLP-1 manufacturing lifecycle
The study is conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of the Medical University of Bialystok (Project identification code: R-I-002/546/2015)
While we take care to keep this information accurate and up to date, changes may occur and we rely on suppliers to notify us accordingly
Who do you think will lead the next breakthrough